Cargando…
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Besides the broad development of nanotechnological approaches for cancer diagnosis and therapy, currently, there is no significant progress in the treatment of different types of brain tumors. Therapeutic molecules crossing the blood–brain barrier (BBB) and reaching an appropriate targeting ability...
Autores principales: | Mitusova, Ksenia, Peltek, Oleksii O., Karpov, Timofey E., Muslimov, Albert R., Zyuzin, Mikhail V., Timin, Alexander S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479308/ https://www.ncbi.nlm.nih.gov/pubmed/36109754 http://dx.doi.org/10.1186/s12951-022-01610-7 |
Ejemplares similares
-
Current outlook on radionuclide delivery systems: from design consideration to translation into clinics
por: Peltek, Oleksii O., et al.
Publicado: (2019) -
Correction to: Current outlook on radionuclide delivery systems: from design consideration to translation into clinics
por: Peltek, Oleksii O., et al.
Publicado: (2020) -
Porous Inorganic Carriers Based on Silica, Calcium Carbonate and Calcium Phosphate for Controlled/Modulated Drug Delivery: Fresh Outlook and Future Perspectives
por: Trofimov, Alexey D., et al.
Publicado: (2018) -
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
por: Hersh, David S., et al.
Publicado: (2016) -
Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting
por: Marianecci, Carlotta, et al.
Publicado: (2017)